EX-99.1 2 ex991.htm MATERIAL CHANGE REPORT - CARDIOME REPORTS SECOND QUARTER RESULTS Material Change Report - Cardiome Pharma Corp. today reported financial results for the second quarter ended June 30, 2006
 
Exhibit 99.1
 
 
FORM 53-901F
 
SECURITIES ACT
 
MATERIAL CHANGE REPORT UNDER
SECTION 85(1) OF THE SECURITIES ACT (BRITISH COLUMBIA)
AND EQUIVALENT LEGISLATION OF OTHER JURISDICTIONS
 
Item 1.
REPORTING ISSUER
 
Cardiome Pharma Corp.
                   6190 Agronomy Road, 6th Floor
Vancouver, BC V6T 1Z3
 
Item 2.
DATE OF MATERIAL CHANGE
 
August 14, 2006
 
Item 3.
PRESS RELEASE
 
August 14, 2006 - Vancouver, British Columbia
 
Item 4.
SUMMARY OF MATERIAL CHANGE
 
Cardiome Pharma Corp. today reported financial results for the second quarter ended June 30, 2006. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP). At close of business on June 30, 2006, the exchange rate was CAD$1.00 = U.S. $0.8959.

Item 5.
FULL DESCRIPTION OF MATERIAL CHANGE

See attached press release

Item 6.
RELIANCE ON SECTION 85(2) OF THE SECURITIES ACT (BRITISH COLUMBIA) AND EQUIVALENT LEGISLATION OF OTHER JURISDICTIONS
 
Not Applicable.
 
Item 7.
OMITTED INFORMATION
 
Not Applicable.
 
Item 8.
SENIOR OFFICER
 
Name:                 Curtis Sikorsky
Title:                  Chief Financial Officer
Phone No.:            604-677-6905
 
Item 9.
STATEMENT OF SENIOR OFFICER
 
The foregoing accurately discloses the material change referred to herein.
 
 

 
Dated at Vancouver, British Columbia, this 14th day of August, 2006.
 
 
 
CARDIOME PHARMA CORP.
Per:   “Curtis Sikorsky”                                                       
      Curtis Sikorsky,
      Chief Financial Officer
 
 
IT IS AN OFFENCE FOR A PERSON TO MAKE A STATEMENT IN A DOCUMENT REQUIRED TO BE FILED OR FURNISHED UNDER THE ACT OR THIS REGULATION THAT, AT THE TIME AND IN THE LIGHT OF THE CIRCUMSTANCES UNDER WHICH IT IS MADE, IS A MISREPRESENTATION.